Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neuronetics (STIM) Asset Utilization Ratio (2018 - 2026)

Neuronetics (STIM) reported Asset Utilization Ratio of 1.14 for Q1 2026, up 79.62% year-over-year from 0.63 in Q1 2025, and up 9.29% on a QoQ basis from 1.04 in Q4 2025.

Neuronetics (STIM) has 9 years of Asset Utilization Ratio data on file, last reported at 1.14 in Q1 2026.

  • Quarterly Asset Utilization Ratio rose 79.62% year-over-year to 1.14 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.14 (up 79.62% YoY) and the FY2025 annual result came in at 1.06, up 81.03% from the prior year.
  • Asset Utilization Ratio climbed to 1.14 in Q1 2026 per STIM's latest filing, from 1.04 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 1.14 in Q1 2026 and bottomed at 0.42 in Q1 2022.
  • The 5-year median for Asset Utilization Ratio is 0.68 (2023), against an average of 0.71.
  • The widest annual swing landed in 2025, when Asset Utilization Ratio decreased 5.16%; it then soared 79.62% in 2026.
  • Tracing STIM's Asset Utilization Ratio over 5 years: stood at 0.55 in 2022, then grew by 23.72% to 0.68 in 2023, then rose by 1.94% to 0.7 in 2024, then jumped by 49.21% to 1.04 in 2025, then rose by 9.29% to 1.14 in 2026.
  • Per Business Quant, the three latest STIM Asset Utilization Ratio figures stand at 1.14 (Q1 2026), 1.04 (Q4 2025), and 0.93 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.46
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.54
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.39
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.47
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.47
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.65
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.74
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.57
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.56
10 Neuronetics 3.26 Mn -6.42 Mn 16.15 Mn 1.14

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.14
Dec 31, 2025 1.04
Sep 30, 2025 0.93
Jun 30, 2025 0.80
Mar 31, 2025 0.63
Dec 31, 2024 0.70
Sep 30, 2024 0.85
Jun 30, 2024 0.72
Mar 31, 2024 0.67
Dec 31, 2023 0.68
Sep 30, 2023 0.72
Jun 30, 2023 0.67
Mar 31, 2023 0.60
Dec 31, 2022 0.55
Sep 30, 2022 0.51
Jun 30, 2022 0.47
Mar 31, 2022 0.42
Dec 31, 2021 0.39
Sep 30, 2021 0.38
Jun 30, 2021 0.36
Mar 31, 2021 0.43
Dec 31, 2020 0.63
Sep 30, 2020 0.64
Jun 30, 2020 0.65
Mar 31, 2020 0.65
Dec 31, 2019 0.61
Sep 30, 2019 0.57
Jun 30, 2019 0.53
Mar 31, 2019 0.48
Dec 31, 2018 0.45
Sep 30, 2018 0.67